Efficacy and Safety of Intravenous rtPA in Ischemic Strokes Due to Small-Vessel Occlusion: Systematic Review and Meta-Analysis

Intravenous recombinant tissue plasminogen activator (iv-rtPA) has been routinely used to treat ischemic stroke for 25 years, following large clinical trials. However, there are few prospective studies on the efficacy and safety of this therapy in strokes attributed to cerebral small vessel disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaszewski, Bartosz, Wyszomirski, Adam, Jabłoński, Bartosz, Werring, David J., Tomaka, Dominika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055574/
https://www.ncbi.nlm.nih.gov/pubmed/33641037
http://dx.doi.org/10.1007/s12975-021-00890-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055574/
https://www.ncbi.nlm.nih.gov/pubmed/33641037
http://dx.doi.org/10.1007/s12975-021-00890-9

Ejemplares similares